Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma

被引:21
作者
Jinawath, Artit
Akiyama, Yoshimitsu
Yuasa, Yasuhito
Pairojkul, Chawalit
机构
[1] Tokyo Med & Dent Univ, Dept Mol Oncol, Grad Sch Med & Dent, Bunkyo Ku, Tokyo 1138519, Japan
[2] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand
关键词
pERK/2; CDX2; MUC2; cholangiocarcinoma; KRAS;
D O I
10.1007/s00432-006-0129-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The extracellular signal-regulated kinase (ERK) 1/2 pathway plays important roles in the regulation of cell proliferation, differentiation and cell survival. The caudal-related homeobox protein CDX2 is essential for the development of the intestine, and is related to gastric and gallbladder cancers with the intestinal phenotype. However, the roles of ERK1/2 phosphorylation (pERK1/2) and CDX2 in cholangiocarcinogenesis remain unknown. We investigated the expression of pERK1/2, CDX2 and MUC2 in Thai cholangiocarcinoma (CCA) specimens by means of immunohistochemical staining, and compared the expression of these proteins with clinicopathological factors. The pERK1/2 protein was expressed in 29 of 59 (49.2%) CCA cases. Interestingly, in tubular-type CCA, the frequency of pERK1/2 expression was associated with a higher grade of differentiation (P = 0.001). CDX2 expression was observed in 22 of the 59 (37.3%) CCA cases, showed a relationship with MUC2 expression (P = 0.001), and was much higher in papillary-type than tubular-type CCA (P = 0.002). These results imply that pERK1/2 may be important for the differentiation of tubular-type CCA, while CDX2 is related to the intestinal phenotype of papillary-type CCA.
引用
收藏
页码:805 / 810
页数:6
相关论文
共 29 条
[1]   Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach [J].
Bai, YQ ;
Yamamoto, H ;
Akiyama, Y ;
Tanaka, H ;
Takizawa, T ;
Koike, M ;
Yagi, OK ;
Saitoh, K ;
Takeshita, K ;
Iwai, T ;
Yuasa, Y .
CANCER LETTERS, 2002, 176 (01) :47-55
[2]  
Beck F, 2000, BIOESSAYS, V22, P431, DOI 10.1002/(SICI)1521-1878(200005)22:5<431::AID-BIES5>3.3.CO
[3]  
2-O
[4]  
Blackhall FH, 2003, CLIN CANCER RES, V9, P2241
[5]   Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention [J].
Chang, F ;
Steelman, LS ;
Lee, JT ;
Shelton, JG ;
Navolanic, PM ;
Blalock, WL ;
Franklin, RA ;
McCubrey, JA .
LEUKEMIA, 2003, 17 (07) :1263-1293
[6]   Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention [J].
Chun, KS ;
Surh, YJ .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) :1089-1100
[7]   Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa [J].
Eda, A ;
Osawa, H ;
Satoh, K ;
Yanaka, I ;
Kihira, K ;
Ishino, Y ;
Mutoh, H ;
Sugano, K .
JOURNAL OF GASTROENTEROLOGY, 2003, 38 (01) :14-22
[8]   ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions [J].
Endo, K ;
Yoon, BI ;
Pairojkul, C ;
Demetris, AJ ;
Sirica, AE .
HEPATOLOGY, 2002, 36 (02) :439-450
[9]   Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater [J].
Hansel, DE ;
Maitra, A ;
Lin, JW ;
Goggins, M ;
Argani, P ;
Yeo, CJ ;
Piantadosi, S ;
Leach, SD ;
Biankin, AV .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :1811-1818
[10]   Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis [J].
Ishikawa, A ;
Sasaki, M ;
Ohira, S ;
Ohta, T ;
Oda, K ;
Nimura, Y ;
Chen, MF ;
Jan, YY ;
Yeh, TS ;
Nakanuma, Y .
LABORATORY INVESTIGATION, 2004, 84 (05) :629-638